Oncology & Cancer
Study links gene to aggressive form of brain cancer
Scientists have identified a gene mutation linked to the development of an aggressive form of brain cancer.
Jun 12, 2015
0
118
Page 16 - News tagged with aggressive cancer
Oncology & Cancer
Nanotechnology shows promise for more accurate prostate cancer screening, prognosis
A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.
Mar 16, 2015
0
29
Medications
Unituxin approved for deadly pediatric cancer
(HealthDay)—Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma, a rare cancer that most often affects children aged five and under.
Mar 11, 2015
0
6
Oncology & Cancer
Researchers learning more about deadly pancreatic cancer
(HealthDay)—Scientists are working to find new ways to treat pancreatic cancer, one of the deadliest types of cancer in the United States.
Jan 30, 2015
0
70
Oncology & Cancer
Researchers discover mechanism leading to drug resistance, metastasis in melanoma
Moffitt Cancer Center researchers have discovered a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it. Targeted biological therapy can reduce toxicity ...
Jan 12, 2015
0
13
Oncology & Cancer
Study finds over-treatment for prostate cancer patients with life expectancies of fewer than 10 years
National guidelines recommend that men with low- and intermediate-risk prostate cancer who have life expectancies of fewer than 10 years should not be treated with radiation or surgery, since they are unlikely to live long ...
Dec 11, 2014
0
0
Oncology & Cancer
Prostate cancer researchers develop personalized genetic test to predict recurrence risk
Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy.
Nov 12, 2014
0
0
Oncology & Cancer
Research explores role of timing, aggression in lung cancer
Western-led research has discovered that timing, in combination with aggression, are possible keys to long-term survival for patients with limited metastatic lung cancer.
Oct 24, 2014
0
0
Oncology & Cancer
Popular prostate cancer therapy may be harmful
A widely used treatment for prostate cancer may cause more harm than good for some patients, according to Dr. Oliver Sartor, medical director of the Tulane Cancer Center.
Oct 23, 2014
0
0
Oncology & Cancer
Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments
A large, international analysis of patients with stage IV non-small cell lung cancer (NSCLC) indicates that a patient's overall survival (OS) rate can be related to factors including the timing of when metastases develop ...
Sep 16, 2014
0
0
